Ying Huang
Stock Analyst at B of A Securities
(2.48)
# 2,320
Out of 4,735 analysts
37
Total ratings
55.56%
Success rate
10.3%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $545 → $522 | $427.89 | +21.99% | 11 | Dec 19, 2024 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $92.96 | -22.55% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $13.56 | +246.61% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $7.57 | +956.80% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $2.15 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $0.87 | +4,491.37% | 2 | Mar 8, 2018 | |
| BLUE bluebird bio | Maintains: Neutral | $3,700 → $4,360 | $8.14 | +53,462.65% | 1 | Feb 22, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $2.98 | +3,759.06% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $3.79 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $140.98 | +158.90% | 1 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $33 | $2.57 | +1,184.05% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $274.81 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Dec 19, 2024
Maintains: Buy
Price Target: $545 → $522
Current: $427.89
Upside: +21.99%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $92.96
Upside: -22.55%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $13.56
Upside: +246.61%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $7.57
Upside: +956.80%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $2.15
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $0.87
Upside: +4,491.37%
bluebird bio
Feb 22, 2018
Maintains: Neutral
Price Target: $3,700 → $4,360
Current: $8.14
Upside: +53,462.65%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $2.98
Upside: +3,759.06%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $3.79
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $140.98
Upside: +158.90%
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $2.57
Upside: +1,184.05%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $274.81
Upside: -